|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.39 USD | +4.81% |
|
+9.61% | +4.63% |
| 07-31 | Atricure Insider Sold Shares Worth $946,000, According to a Recent SEC Filing | MT |
| 07-28 | UBS Adjusts Price Target on AtriCure to $50 From $55, Maintains Buy Rating | MT |
Company Valuation: AtriCure, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,194 | 2,064 | 1,692 | 1,490 | 1,967 | 2,105 | - | - |
| Change | - | -35.37% | -18.05% | -11.92% | 32.01% | 7.04% | - | - |
| Enterprise Value (EV) 1 | 3,210 | 2,063 | 1,623 | 1,441 | 1,873 | 1,952 | 1,878 | 1,783 |
| Change | - | -35.73% | -21.32% | -11.21% | 29.97% | 4.25% | -3.8% | -5.06% |
| P/E | 63.8x | -43.5x | -54.1x | -32.2x | -165x | 392x | 98.8x | 59.6x |
| PBR | 6.61x | 4.52x | 3.55x | 3.24x | 4x | 3.65x | 3.25x | 2.84x |
| PEG | - | 0x | 1.5x | -0.7x | 2.2x | -3x | 0x | 0.9x |
| Capitalization / Revenue | 11.6x | 6.25x | 4.24x | 3.2x | 3.68x | 3.47x | 3.1x | 2.75x |
| EV / Revenue | 11.7x | 6.24x | 4.06x | 3.1x | 3.5x | 3.22x | 2.76x | 2.33x |
| EV / EBITDA | -366x | -943x | 83.5x | 46.3x | 30.3x | 22.3x | 18.5x | 14.4x |
| EV / EBIT | -67.9x | -48.3x | -60.8x | -36x | -198x | 170x | 75.2x | 41.9x |
| EV / FCF | -136x | -52.9x | -216x | 1,934x | 38.8x | 36.8x | 46.9x | - |
| FCF Yield | -0.73% | -1.89% | -0.46% | 0.05% | 2.58% | 2.72% | 2.13% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.09 | -1.02 | -0.66 | -0.95 | -0.24 | 0.1056 | 0.4188 | 0.6947 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 274.3 | 330.4 | 399.2 | 465.3 | 534.5 | 606.2 | 679.6 | 764.6 |
| EBITDA 1 | -8.776 | -2.188 | 19.45 | 31.12 | 61.77 | 87.37 | 101.6 | 123.9 |
| EBIT 1 | -47.3 | -42.67 | -26.68 | -40.01 | -9.447 | 11.46 | 24.98 | 42.51 |
| Net income 1 | 50.2 | -46.47 | -34.85 | -44.7 | -11.45 | 7.12 | 20.79 | 35.23 |
| Net Debt 1 | 16.09 | -1.265 | -68.63 | -49 | -94.05 | -153 | -227.2 | -322.2 |
| Reference price 2 | 69.53 | 44.38 | 35.69 | 30.56 | 39.56 | 41.39 | 41.39 | 41.39 |
| Nbr of stocks (in thousands) | 45,932 | 46,508 | 47,395 | 48,753 | 49,717 | 50,866 | - | - |
| Announcement Date | 15/2/22 | 21/2/23 | 15/2/24 | 12/2/25 | 17/2/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 392.03x | 3.22x | 22.34x | - | 2.11B | |
| 30.94x | 4.19x | 16.22x | 2.38% | 187B | |
| 19.75x | 3.44x | 12.1x | 3.41% | 112B | |
| 17.52x | 0.2x | 12.83x | 0.74% | 61.15B | |
| 31.31x | 7.81x | 19.88x | 1.27% | 54.39B | |
| 34.29x | 3.31x | 11.26x | 2.22% | 48.17B | |
| 33.97x | 5.97x | 18.74x | -.--% | 31.98B | |
| 41.84x | 1.3x | 11.77x | 0.16% | 30.91B | |
| 41.29x | 7.23x | 25.96x | 0.25% | 24.92B | |
| 25.57x | 3.88x | 13.52x | 1.12% | 23.15B | |
| Average | 66.85x | 4.06x | 16.46x | 1.29% | 57.49B | |
| Weighted average by Cap. | 29.97x | 3.95x | 15.23x | 1.89% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ATRC Stock
- Valuation AtriCure, Inc.
Select your edition
All financial news and data tailored to specific country editions
